Daniela Corna Selected Research

2,2,3,3,5,5- hexamethyl- 1- pyrrolidinyloxyl

1/2021

Characterization of a Rat Model of Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Crescentic Glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Corna Research Topics

Disease

24	Proteinuria 01/2021 - 05/2002
12	Inflammation (Inflammations) 10/2019 - 05/2002
11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 07/2003
7	Disease Progression 06/2011 - 05/2002
5	Albuminuria 01/2022 - 03/2013
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2007
5	Chronic Renal Insufficiency 01/2020 - 01/2007
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2011
4	Membranous Glomerulonephritis (Membranous Nephropathy) 06/2006 - 05/2002
3	Hemolytic-Uremic Syndrome 01/2022 - 10/2012
3	Glomerulonephritis 01/2021 - 06/2006
3	Renal Insufficiency (Renal Failure) 01/2021 - 12/2002
3	Fibrosis (Cirrhosis) 12/2019 - 11/2009
2	Thrombosis (Thrombus) 01/2022 - 08/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2019
2	Microvascular Rarefaction 10/2019 - 11/2012
2	Sclerosis 01/2016 - 01/2006
2	Cysts 01/2015 - 01/2015
1	Hypoxia (Hypoxemia) 01/2021
1	Anemia 01/2021
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 12/2019
1	Heart Failure 12/2019
1	Hypertrophy 12/2019
1	Cardiac Arrhythmias (Arrythmia) 10/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2015
1	Neoplasms (Cancer) 03/2014
1	Dyslipidemias (Dyslipidemia) 03/2013
1	Body Weight (Weight, Body) 03/2013

Drug/Important Bio-Agent (IBA)

9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 05/2002
8	Lisinopril (Prinivil)FDA LinkGeneric 10/2019 - 05/2002
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2002
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 05/2002
5	Angiotensin IIIBA 10/2019 - 07/2003
4	Complement System Proteins (Complement)IBA 12/2020 - 06/2008
4	Streptozocin (Streptozotocin)FDA Link 01/2016 - 01/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2010 - 05/2002
3	nephrinIBA 01/2022 - 11/2009
3	Shiga Toxin (Shigella Toxin)IBA 01/2022 - 10/2012
3	Sirtuin 3IBA 01/2020 - 10/2017
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2007
2	Bovine Serum AlbuminIBA 01/2018 - 10/2003
2	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 11/2007
2	AntioxidantsIBA 10/2017 - 03/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015 - 11/2011
2	Endothelin-1 (Endothelin 1)IBA 03/2014 - 09/2003
2	Ramipril (Altace)FDA LinkGeneric 01/2013 - 11/2011
2	Blood Proteins (Serum Proteins)IBA 06/2011 - 06/2008
2	candesartanIBA 11/2010 - 06/2006
2	Rosuvastatin Calcium (Crestor)FDA Link 11/2010 - 01/2007
2	Type 1 Angiotensin ReceptorIBA 11/2009 - 10/2004
2	FicollIBA 11/2009 - 01/2007
2	Angiotensin Receptor AntagonistsIBA 06/2006 - 12/2002
2	Enalapril FDA LinkGeneric 01/2006 - 11/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2006 - 07/2003
2	CholesterolIBA 12/2002 - 05/2002
1	NestinIBA 01/2022
1	Shiga Toxin 2IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	empagliflozinIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	NitrogenIBA 01/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Erythropoietin FDA Link 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	2,2,3,3,5,5- hexamethyl- 1- pyrrolidinyloxylIBA 01/2021
1	HematinicsIBA 01/2021
1	Conditioned Culture MediaIBA 01/2020
1	honokiolIBA 01/2020
1	lanthionineIBA 10/2019
1	angiotensin I (1-7)IBA 10/2019
1	LigandsIBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	Peptide Hydrolases (Proteases)FDA Link 10/2019
1	Connexin 43 (Connexin43)IBA 10/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2018
1	dapagliflozinIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 10/2017
1	AntibodiesIBA 04/2016
1	Abatacept (Orencia)FDA Link 04/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	Fibronectins (Fibronectin)IBA 01/2016
1	bindaritIBA 01/2015
1	ArrestinIBA 03/2014
1	Endothelin A ReceptorIBA 03/2014
1	bardoxoloneIBA 03/2013
1	TriterpenesIBA 03/2013
1	bardoxolone methylIBA 03/2013
1	Transaminases (Aminotransferases)IBA 03/2013
1	2- cyano- 3,12- dioxooleana- 1,9(11)- dien- 28- oic acid ethyl amideIBA 03/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012
1	LectinsIBA 10/2012

Therapy/Procedure

13	Therapeutics 01/2018 - 05/2002
2	Kidney Transplantation 04/2016 - 01/2015
1	Injections 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021